Company / Gross Profit per Share
ResMed Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$20.80
FY2025
5-year range
$12.69 / $20.80
FY2021-FY2025
Trend
+15.2%
vs FY2024
Sector context
#23 of 94
Health Care
What the data says
ResMed's gross profit per share of $20.80 is higher than 76% of companies in the Health Care sector (FY2025). Gross Profit per Share has increased for 9 consecutive years, from $7.59 in FY2016 to $20.80 in FY2025.
Based on SEC 10-K filings.
20.80 in FY2025 with a 5-year CAGR of +11.7%. Top quartile in the Health Care sector.
Improved from $16.09 to $20.80 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +14.4%
- 5-Year CAGR
- +11.7%
- 10-Year CAGR
- -
Sector benchmark
+45.6% above sector average
Key checks
Key Insights
- ResMed's gross profit per share has grown for 9 consecutive years.
- In FY2025, gross profit per share increased 15.2% year-over-year.
- Ranks #23 out of 94 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.80 | +15.2% |
| FY2024 | $18.06 | +12.2% |
| FY2023 | $16.09 | +15.8% |
| FY2022 | $13.90 | +9.5% |
| FY2021 | $12.69 | +6.2% |
| FY2020 | $11.96 | +14.2% |
| FY2019 | $10.47 | +11.5% |
| FY2018 | $9.39 | +9.9% |
| FY2017 | $8.54 | +12.5% |
| FY2016 | $7.59 | +5.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026